Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Adebrelimab Combined With Neoadjuvant Chemotherapy in Borderline Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

Sun Yat-sen University · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
chemotherapyimmune-checkpoint-inhibitor
esophageal squamous cell carcinoma (escc), adebrelimab, chemotherapy, neoadjuvent, immune checkpoint inhibitor, borderline resectable, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 851472
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.